In conclusion, TQ mediated anti-leukemia effects on MV4-11 AML cells by creating a balance in the expression of the epigenetic regulator genes through downregulating DNMT1, DNMT3A, and DNMT3B and upregulating TET2 and WT1, resulting in a reduction in DNA methylation levels of SHP-1 and SOCS-3 and restoration of their expression. The gene discussed is TET2; the disease is leukemia.